These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 17394133

  • 1. Lysyl oxidase-like 2 expression is increased in colon and esophageal tumors and associated with less differentiated colon tumors.
    Fong SF, Dietzsch E, Fong KS, Hollosi P, Asuncion L, He Q, Parker MI, Csiszar K.
    Genes Chromosomes Cancer; 2007 Jul; 46(7):644-55. PubMed ID: 17394133
    [Abstract] [Full Text] [Related]

  • 2. Lysyl oxidase-like 2 as a new poor prognosis marker of squamous cell carcinomas.
    Peinado H, Moreno-Bueno G, Hardisson D, Pérez-Gómez E, Santos V, Mendiola M, de Diego JI, Nistal M, Quintanilla M, Portillo F, Cano A.
    Cancer Res; 2008 Jun 15; 68(12):4541-50. PubMed ID: 18559498
    [Abstract] [Full Text] [Related]

  • 3. Lysyl oxidase-like 2 promotes migration in noninvasive breast cancer cells but not in normal breast epithelial cells.
    Hollosi P, Yakushiji JK, Fong KS, Csiszar K, Fong SF.
    Int J Cancer; 2009 Jul 15; 125(2):318-27. PubMed ID: 19330836
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Down-regulation of lysyl oxidase-like 2 (LOXL2) is associated with disease progression in lung adenocarcinomas.
    Zhan P, Shen XK, Qian Q, Zhu JP, Zhang Y, Xie HY, Xu CH, Hao KK, Hu W, Xia N, Lu GJ, Yu LK.
    Med Oncol; 2012 Jun 15; 29(2):648-55. PubMed ID: 21519871
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Forkhead box A1 transcriptional pathway in KRT7-expressing esophageal squamous cell carcinomas with extensive lymph node metastasis.
    Sano M, Aoyagi K, Takahashi H, Kawamura T, Mabuchi T, Igaki H, Tachimori Y, Kato H, Ochiai A, Honda H, Nimura Y, Nagino M, Yoshida T, Sasaki H.
    Int J Oncol; 2010 Feb 15; 36(2):321-30. PubMed ID: 20043065
    [Abstract] [Full Text] [Related]

  • 11. Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers.
    Zou B, Chim CS, Zeng H, Leung SY, Yang Y, Tu SP, Lin MC, Wang J, He H, Jiang SH, Sun YW, Yu LF, Yuen ST, Kung HF, Wong BC.
    Gastroenterology; 2006 Dec 15; 131(6):1835-43. PubMed ID: 17087954
    [Abstract] [Full Text] [Related]

  • 12. Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer.
    Chen W, Gao N, Shen Y, Cen JN.
    J Gastroenterol Hepatol; 2010 Apr 15; 25(4):823-31. PubMed ID: 20492341
    [Abstract] [Full Text] [Related]

  • 13. FHIT expression and hypermethylation in esophageal squamous cell carcinoma.
    Noguchi T, Takeno S, Kimura Y, Uchida Y, Daa T, Yokoyama S, Gabbert HE, Mueller W.
    Int J Mol Med; 2003 Apr 15; 11(4):441-7. PubMed ID: 12632095
    [Abstract] [Full Text] [Related]

  • 14. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J, Luo RZ, Fujii S, Wang L, Hu W, Andreeff M, Pan Y, Kadota M, Oshimura M, Sahin AA, Issa JP, Bast RC, Yu Y.
    Cancer Res; 2003 Jul 15; 63(14):4174-80. PubMed ID: 12874023
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. 5' CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer.
    Zöchbauer-Müller S, Fong KM, Maitra A, Lam S, Geradts J, Ashfaq R, Virmani AK, Milchgrub S, Gazdar AF, Minna JD.
    Cancer Res; 2001 May 01; 61(9):3581-5. PubMed ID: 11325823
    [Abstract] [Full Text] [Related]

  • 17. 5-Aza-2'-deoxycytidine induces retinoic acid receptor-beta(2) demethylation and growth inhibition in esophageal squamous carcinoma cells.
    Liu Z, Zhang L, Ding F, Li J, Guo M, Li W, Wang Y, Yu Z, Zhan Q, Wu M, Liu Z.
    Cancer Lett; 2005 Dec 18; 230(2):271-83. PubMed ID: 16297713
    [Abstract] [Full Text] [Related]

  • 18. Identification of a novel lysyl oxidase-like 2 alternative splicing isoform, LOXL2 Δe13, in esophageal squamous cell carcinoma.
    Lv GQ, Zou HY, Liao LD, Cao HH, Zeng FM, Wu BL, Xie JJ, Fang WK, Xu LY, Li EM.
    Biochem Cell Biol; 2014 Oct 18; 92(5):379-89. PubMed ID: 25275797
    [Abstract] [Full Text] [Related]

  • 19. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.
    Tanaka K, Imoto I, Inoue J, Kozaki K, Tsuda H, Shimada Y, Aiko S, Yoshizumi Y, Iwai T, Kawano T, Inazawa J.
    Oncogene; 2007 Sep 27; 26(44):6456-68. PubMed ID: 17438526
    [Abstract] [Full Text] [Related]

  • 20. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing.
    Gonzalez-Zulueta M, Bender CM, Yang AS, Nguyen T, Beart RW, Van Tornout JM, Jones PA.
    Cancer Res; 1995 Oct 15; 55(20):4531-5. PubMed ID: 7553622
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.